Stelliam Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$45.5M |
| 2 |
Citigroup
C
|
+$41.6M |
| 3 |
MON
Monsanto Co
MON
|
+$38.2M |
| 4 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
+$35.4M |
| 5 |
Chemed
CHE
|
+$28.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$69.4M |
| 2 |
Capital One
COF
|
+$48.1M |
| 3 |
SNDK
SANDISK CORP
SNDK
|
+$26.3M |
| 4 |
Louisiana-Pacific
LPX
|
+$24.3M |
| 5 |
Seagate
STX
|
+$19.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 19.46% |
| 2 | Technology | 17.35% |
| 3 | Industrials | 13.76% |
| 4 | Energy | 12.86% |
| 5 | Financials | 11.75% |
Similar funds
Stelliam Investment Management's Q4 2013 Portfolio in Review
As of Q4 2013, Stelliam Investment Management held 60 positions worth $2.45B, up 17% from $2.1B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Stelliam Investment Management deployed $82.4M of net new capital in Q4 2013, opening 8 new positions and adding to 29 existing holdings. Its largest new stake was Amgen: 400,000 shares worth $45.7M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 17% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was SANDISK CORP, an estimated $26.3M trimmed.
- Stelliam Investment Management's largest Q4 2013 buy was Amgen: 400,000 shares worth $45.7M.
- Stelliam Investment Management added most to GameStop in Q4 2013, an estimated $19.7M increase.
- Stelliam Investment Management's biggest Q4 2013 reduction was SANDISK CORP, cutting an estimated $26.3M.
- Stelliam Investment Management fully exited Teva Pharmaceuticals in Q4 2013, selling an estimated $69.4M.
- Stelliam Investment Management's ten largest holdings make up 33% of its $2.45B portfolio in Q4 2013.
- Stelliam Investment Management opened 8 new positions and closed 10 in Q4 2013.
- Stelliam Investment Management's portfolio value rose 17% quarter-over-quarter to $2.45B.
Based on Stelliam Investment Management's 13F filing for Q4 2013, filed 14 Feb 2014.